The survival impact of upfront or sequential chemoradiotherapy in locally advanced esophageal squamous cell carcinoma

BackgroundThe treatment of locally advanced unresectable esophageal squamous cell carcinoma (ESCC) is a clinical challenge with limited therapeutic consensus. The immune checkpoint inhibitor (ICI)-based conversion therapies emerged as an option besides definitive chemoradiotherapy (DCRT). Especially...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Xuechun Luo, Fan Peng, Xi Lin, Yun Li, Zhenyu Ding
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2026-04-01
Edice:	Frontiers in Oncology
Témata:	conversion therapy definitive chemoradiotherapy (dCRT) esophageal squamous cell carcinoma (ESCC) immune checkpoint inhibitors (ICBs) multicenter analysis survival analysis
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fonc.2026.1785745/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!